WO1995027197A1 - System for ph-neutral longlife precast electrophoresis gel - Google Patents

System for ph-neutral longlife precast electrophoresis gel Download PDF

Info

Publication number
WO1995027197A1
WO1995027197A1 PCT/US1995/003647 US9503647W WO9527197A1 WO 1995027197 A1 WO1995027197 A1 WO 1995027197A1 US 9503647 W US9503647 W US 9503647W WO 9527197 A1 WO9527197 A1 WO 9527197A1
Authority
WO
WIPO (PCT)
Prior art keywords
gel
tris
buffer
buffer solution
electrophoresis
Prior art date
Application number
PCT/US1995/003647
Other languages
French (fr)
Inventor
Sheldon Engelhorn
Timothy V. Updyke
Original Assignee
Novel Experimental Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22830063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1995027197(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novel Experimental Technology filed Critical Novel Experimental Technology
Priority to JP52575995A priority Critical patent/JP3679117B2/en
Priority to EP95914833A priority patent/EP0753142B1/en
Priority to DE69511389T priority patent/DE69511389T2/en
Priority to CA002186120A priority patent/CA2186120C/en
Priority to AU21926/95A priority patent/AU698145B2/en
Publication of WO1995027197A1 publication Critical patent/WO1995027197A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44704Details; Accessories
    • G01N27/44747Composition of gel or of carrier mixture

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A gel and buffer system for gel electrophoresis wherein separation occurs at neutral pH and proteins remain completely reduced.

Description


  
 



   SYSTEM FOR PH-NEUTRAL LONGLIFE
 PRECAST ELECTROPHORESIS GEL
 This invention relates to techniques for gel electrophoresis. More particularly this invention relates to a novel system for gel electrophoresis at approximately neutral pH.



  Background Of the Invention
 Gel electrophoresis is a common procedure for the separation of biological molecules, such as DNA,
RNA, polypeptides and proteins. In gel electrophoresis, the molecules are separated into bands according to the rate at which an imposed electric field causes them to migrate through a filtering gel.



   The basic apparatus used in this technique consists of a gel enclosed in a glass tube or sandwiched as a slab between glass or plastic plates.



  The gel has an open molecular network structure, defining pores which are saturated with an electrically conductive buffered solution-of a salt. These pores through the gel are large enough to admit passage of the migrating macromolecules.



   The gel is placed in a chamber in contact with buffer solutions which make electrical contact between the gel and the cathode or anode of an electrical power supply. A sample containing the  macromolecules and a tracking dye is placed on top of the gel. An electric potential is applied to the gel causing the sample macromolecules and tracking dye to migrate toward the bottom of the gel. The electrophoresis is halted just before the tracking dye reaches the end of the gel. The locations of the bands of separated macromolecules are then determined. By comparing the distance moved by particular bands in comparison to the tracking dye and macromolecules of known mobility, the mobility of other macromolecules can be determined. The size of the macromolecule can then be calculated.



   The rate of migration of macromolecules through the gel depends upon three principle factors: the porosity of the gel; the size and shape of the macromolecule; and the charge density of the macromolecule. It is critical to an effective electrophoresis system that these three factors be precisely controlled and reproducible from gel to gel and from sample to sample. However, maintaining uniformity between gels is difficult because each of these factors is sensitive to many variables in the chemistry of the gel system.



   Polyacrylamide gels are commonly used for electrophoresis. Polyacrylamide gel electrophoresis or
PAGE is popular because the gels are optically transparent, electrically neutral and can be made with a range of pore sizes. The porosity of a polyacrylamide gel is in part defined by the total percentage of acrylamide monomer plus crosslinker monomer   ("%T")    it contains. The greater the concentration, the less space there is between strands of the polyacrylamide matrix and hence the smaller the pores through the gel. An 8% polyacrylamide gel has larger pores than a 12% polyacrylamide gel. An 8%  polyacrylamide gel consequently permits faster migration of macromolecules with a given shape, size and charge density. When smaller macromolecules are to be separated, it is generally preferable to use a gel with a smaller pore size such as a 20% gel.

  Conversely for separation of larger macromolecules, a gel with a larger pore size is often used, such as an 8% gel.



   Pore size is also dependent upon the amount of crosslinker used to polymerize the gel. At any given total monomer concentration, the minimum pore size for a polyacrylamide gel is obtained when the ratio of total monomer to crosslinker is about 20:1, (the usual expression for this ratio would be "5%C").



   Several factors may cause undesirable variation in the pore size of gels. Pore size can be increased by incomplete gel polymerization during manufacture. Hydrolysis of the polyacrylamide after polymerization can create fixed negative charges and break down the crosslinks in the gel, which will degrade the separation and increase the pore size. An ideal gel system should have a reproducible pore size and no fixed charge (or at least a constant amount) and should be resistant to change in chemical characteristics or the pore size due to hydrolysis.



   The size of the macromolecule varies between different macromolecules; the smaller and more compact the macromolecule the easier it will be for the macromolecule to move through the pores of a given gel.



  Given a constant charge density, the rate of migration of a macromolecule is inversely proportional to the logarithm of its size.



   For accurate and reproducible electrophoresis, a given type of macromolecule should preferably take on a single form in the gel. One difficulty with maintaining uniformity of the shape of  proteins during gel electrophoreses is that disulfide bonds can be formed by oxidation of pairs of cysteine amino acids. Different oxidized forms of the protein then have different shapes and, therefore, migrate through the gel run with slightly different mobilities (usually faster than a completely reduced protein, since the maximum stokes radius and minimum mobility should occur with a completely unfolded form). A heterogeneous mixture of forms leads to apparent band broadening. In order to prevent the formation of disulfide bonds, a reducing agent such as dithiothreitol (DTT) is usually added to the samples to be run.



   The charge density of the migrating molecule is the third factor affecting its rate of migration through the gel -- the higher the charge density, the more force will be imposed by the electric field upon the macromolecule and the faster the migration rate subject to the limits of size and shape. In SDS-PAGE electrophoresis the charge density of the macromolecules is controlled by adding sodium dodecyl sulfate ("SDS") to the system. SDS molecules associate with the macromolecules and impart a uniform charge density to them substantially negating the effects of any innate molecular charge.



   SDS PAGE gels are usually poured and run at basic pH. The most common PAGE buffer system employed for the separation of proteins is that developed by
Ornstein (1) and modified for use with SDS by Laemmli (2). Laemmli, U.K. (1970) Nature 227, 680-686. The
Laemmli buffer system consists of 0.375 M Tris (tris (hydroxy methyl) amino-methane), titrated to pH 8.8.



  with   HC1,    in the separating gel. The stacking gel consists of 0.125 M Tris, titrated to pH 6.8. The anode and cathode running buffers contain 0.024 M Tris,  0.192 M glycine, 0.1% SDS. An alternative buffer system is disclosed by Schaegger and von Jagow.



  Schagger, H. and von Jagow, G., Anal. Biochem. 1987, 166, 368-379. The stacking gel contains 0.75 M Tris, titrated to pH 8.45 with   HC1.    The separating gel contains 0.9 M Tris, titrated to pH 8.45 with   HC1.    The cathode buffer contains 0.1 M Tris, 0.1M Tricine, 0.1%
SDS. The anode buffer contains 0.2 M Tris, titrated to pH 8.9 with   HC1.    For both of these systems Tris is the "common ion" which is present in the gel and in the anode and cathode buffers.



   In the Laemmli system, the pH of the trailing phase in the stacking gel is about 8.9. In the separating gel, the trailing phase pH is about 9.7. At this pH, primary amino groups of proteins react readily with unpolymerized acrylamide, thiol groups are more subject to oxidation to   disulf ides,    or reaction with unpolymerized polyacrylamide, than at neutral pH and acrylamide itself is subject to hydrolysis.

 

   The need for uniformity and predictability is magnified in precast electrophoresis gels which are manufactured by an outside vendor and then shipped to the laboratory where the electrophoresis will be performed. Precast gels must control the properties discussed above and they must be able to maintain this control throughout shipping and storage. The shelf life of many precast gels is limited by the potential for hydrolysis of acrylamide during storage at the high pH of the gel buffer.



   It is a disadvantage of a high pH gel that the polyacrylamide gel is subject to degradation by hydrolysis and has a limited shelf-life.



   It is a further disadvantage of a high pH gel that proteins react readily with unpolymerized  acrylamide which may interfere with subsequent analysis of the protein such as peptide sequencing.



   It is a still further disadvantage of a high pH gel that thiol groups are subject to oxidation to   disulf ides    causing a decreased resolution of separated macromolecules.



     Summarv    of the Invention
 It is an object of this invention to produce a neutral gel system that reduces protein reaction with unpolymerized acrylamide thereby enhancing yield and resolution.



   It is a further object of this invention to produce a neutral gel system that prevents formation of   disulf ides    from free thiol groups thereby enhancing yield and resolution.



   It is a still further object of this invention to produce a neutral gel system that reduces degradation of the polyacrylamide gel by hydrolysis thereby increasing the useful shelf-life of a precast gel.



   In accordance with this invention, applicants describe a gel and buffer system wherein separation occurs at neutral pH and proteins remain completely reduced. The above and other objects and advantages of the present invention will be apparent upon consideration of the following detailed description.



  Detailed Description Of   The-Invention   
 Applicants describe a gel and buffer system wherein separation occurs at neutral pH and proteins remain completely reduced. Advantageously, at this neutral pH, primary amino groups of proteins react less readily with unpolymerized acrylamide because protonation of protein amino groups greatly reduces  their reactivity to acrylamide or other related blocking agents. Furthermore, at this neutral pH, thiol groups are less subject to oxidation than at higher pH and polyacrylamide itself is less subject to hydrolysis.



   The result is a gel system with improved stability of the gel matrix and stock solutions. Gels prepared according to this system can be stored under refrigeration for over a year without loss of performance due to acrylamide hydrolysis. Also, stock buffers without reducing agents and stock gel solutions without polymerization initiator can be stored for at least several weeks at room temperature with no loss of performance. An additional benefit is that a single gel recipe, using the same buffer for the stacking and separating gels, can be used with two different running buffers to give two separation systems. Using this feature, an 8% gel, for example, can cover a protein separation range of 2 to 200 kDa.



   In one embodiment of this invention a polyacrylamide gel of between about 3% and about 25% (%T) acrylamide is polymerized using from about 1% to about 6% crosslinker (%C) using a gel buffer comprising a primary organic amine or substituted amine with a pK near neutrality, titrated with approximately half as much   HC1    (on a molar basis), so that the pH of the buffer is approximately neutral.

  In a preferred embodiment the gel is polymerized using from about 2% to about 5% crosslinker   (%C) using    a gel buffer comprising Bis-Tris [Bis-(2-hydroxyethyl) iminotris (hydroxymethyl) methane] titrated with   HC1.    Different separation characteristics can be obtained by running the gel with either a MOPS (3-[N-Morpholino] propanesulfonic acid) or MES (2-(N-Morpholino) ethanesulfonic acid), buffer. 2mM to 10 mM TGA or 2mM  to 10mM sodium bisulfite is added to the running buffer to maintain a reducing environment in the gel during electrophoresis. This and other embodiments can be understood by reference to the following illustrative and comparative examples.



   Examples
 Bis-Tris, MES, and MOPS were purchased from
Sigma (St. Louis, MO) or Research Organics (Cleveland,
Ohio). Thiogycollic acid (TGA), DTT and mercaptoethanol (BME) were from Sigma. All other chemicals were reagent, "ultra pure" or "electrophoresis grade" from standard sources. Gels were cast in 1 mm thickness mini-gel cassettes from
Novex (San Diego CA) and run in a Novex minicell.



   The Bis-Tris separating gel and stacking gels were prepared from a   30%T/2.5%C    acrylamide/BIS stock solution and a 7X Bis-Tris stock solution (2.5M Bis
Tris, 1.5M   HC1,    pH 6.5). To prepare the separating gel, the stock solutions were blended with ultra pure water to a final concentration 8%T, 0.357M Bis-Tris, to which was added 0.2 ul/ml temed. After degassing, 2.Oul/ml of a 10% solution of APS was added, the gel was immediately poured into the cassette then overlaid with water. Polymerization was allowed to proceed for at least 30 minutes at   RT!    the water was removed and a 4% stacking gel applied.

  The stacking gel was prepared in the same fashion as the separating gel, except that the final concentration obtained was 4%T, temed concentration was increased to 0.4ul/ml and the APS increased to   5.Oultml.   



   MOPS running buffer consisted of 50mM MOPS, 50mM Bis-Tris (or TRIS), 0.1% SDS,   lmM    EDTA. MES running buffer consisted of 50mM MES, 50mM Bis-Tris (or
TRIS), 0.1% SDS,   lmM    EDTA. Sample buffer (2X)  consisted of 0.25M Bis-Tris,   0.15M      HC1,    10% (w/v)
Glycerol, 2% SDS,   lmM    EDTA, 0.03% Serva Blue G, and 200mM DTT. Samples containing a set of protein standards were heated for 15 min at 70 degrees before application. Bovine serum albumin (BSA), chicken egg ovalbumin, alkylated insulin A and B chain, soybean trypsin inhibitor, and bovine erythrocyte carbonic anhydrase were included in the standard. Sample volume was 5ul in all cases.



   Example 1
 The protein standards were separated on an 8%
Bis-Tris gel with MOPS running buffer in the absence of a reducing agent. The resulting separation pattern was very similar to that obtained on an 8% TRIS/glycine gel (Laemmli), with proteins 20,000 and smaller remaining in the stack along with the tracking dye. The BSA band was somewhat diffuse and shifted toward the anode. The
Ovalbumin band was also somewhat diffuse.

 

   Example 2
 The protein standards were separated on an 8%
Bis-Tris gel with MOPS running buffer in the presence of TGA in the cathode buffer. Again, the separation pattern was very similar to that obtained on an 8%
TRIS/glycine (Laemmli) gel, with proteins 20,000 and smaller remaining in the stack along with the tracking dye. The presence of the reducing agent, 5mM TGA, in the cathode buffer provided for better resolution of the proteins BSA and Ovalbumin compared to the gel run without TGA.



   Example 3
 The protein standards were separated on an 8%
Bis-Tris gel with MOPS running buffer in the presence  of sodium bisulfite in the cathode buffer. Again, the separation pattern was very similar to that obtained on an 8% TRIS/glycine (Laemmli) gel, with proteins 20,000 and smaller remaining in the stack along with the tracking dye. The presence of the reducing agent, 5mM sodium bisulfite, in the cathode buffer provided for better resolution of the proteins BSA and Ovalbumin compared to the gel run without sodium bisulfite.



   ExamPle 4
 The protein standards were spearated on an 8%
Bis-Tris gel with MES running buffer in the absence of a reducing agent. The protein separation was very similar to that obtained from a 12% TRIS/tricine (Schaegger) gel. All proteins were resolved from the stack including insulin A and B chain (3500 and 2500 daltons, respectively). When the gel is run without
TGA, soybean trypsin inhibitor had a more prominent doublet.



   Example 5
 The protein standards were separated on an 8%
Bis-Tris/Cl gel with Bis-Tris/MES running buffer in the presence of TGA in the cathode buffer. Again, all proteins were resolved from the stack including insulin
A and B chain (3500 and 2500 daltons, respectively).



  The presence of the reducing agent, 5mM TGA, in the cathode buffer provided for better resolution of the protein soybean trypsin inhibitor. Carbonic anhydrase ran as a tight, sharp band under all conditions tested.



   ExamDle 6
 The protein standards were separated on an 8%
Bis-Tris/Cl gel with Bis-Tris/MES running buffer in the presence of sodium bisulfite in the cathode buffer.



  Again, all proteins were resolved from the stack  including insulin A and B chain (3500 and 2500 daltons, respectively). The presence of the reducing agent, 5mM sodium bisulfite, in the cathode buffer provided for better. resolution of the protein soybean trypsin inhibitor. Carbonic anhydrase ran as a tight, sharp band under all conditions tested.



   Although MES and MOPS were selected as desirable running buffers because the resulting system has separation characteristics similar to the commonly used Laemmli and Schaegger gel systems, it was found that a range of buffers are suitable for use in this system. Among the additional buffers giving good results were ACES   ([N- (2-Acetomido) ] -2-    aminoethanesulfonic acid, MOPSO   (2-[N-Morpholino) -2-    hydroxypropanesulfonic acid, TES (N-Tris   (hydroxymethyl) -2-ethanesulfonic    acid, BES (N,N-BIS   (Hydroxyethyl) -2-aminoethanesulfonic    acid, HEPES (N-2
Hydroxyethyl-piperazine-n-2-ethanesulfonic acid), TAPSO (3-(N-tris-(Hydroxymethyl) methylamino)-2hydroxypropanesulfonic acid.



   All the proteins that exhibit some band broadening and/or mobility shifts when run in the absence of TGA or sodium bisulfite, have in common a composition that includes multiple cysteines (BSA, for instance, has 35 cysteines). On the other hand carbonic anhydrase, which always runs cleanly, has no cysteines. Moreover, if the reduced proteins are alkylated before running, they run as sharp homogeneous bands even in the absence of a reducing agent.



   Cysteine-containing proteins appear to give generally sharper bands in the Laemmli system than the neutral system, when both are run with 100mM mercaptoethanol or DTT in the sample buffer but without
TGA in the running buffer. Since thiol oxidation is more favored as the pH increases, it would be expected  that the higher pH of the Laemmli system would cause oxidation of disulfide to be at least as pronounced as it is in the neutral pH system. However, DTT and similar "neutral" thiol reducing agents are weak acids (with pKa's around pH 8-9). Thus, at basic pH, these reducing agents migrate into the gel and, if present at sufficient concentration, provide some protection against oxidation of sulfhydryls. At a neutral separating pH, DTT from the sample buffer is in an uncharged form and will remain behind in the sample well. Thus, no reducing agent migrates into the gel.



   To maintain proteins in a reduced form during electrophoresis at neutral pH, it was found advantageous to use a reducing agent that would migrate into the gel at neutral pH. Sodium Bisulfite (2-10mM) was found to maintain a reducing environment in the gel during electrophoresis. Fully reduced TGA (or similar negatively charged thiols) give similar results at comparable concentrations. However, partially oxidized
TGA will promote partial oxidation of protein thiols.



  Because reduction (oxidation) of protein thiols will take place via disulfide interchange, the ratio of reduced to oxidized thiols in the protein will substantially reflect the ratio of reduced to oxidized thiols in the TGA. Conversely, sulfite oxidizes to sulfate, which does not participate in redox reactions under conditions found in the gel. Therefore, regardless of the sulfite/sulfate ratio in a partially oxidized preparation of sulfite, as long as sufficient sulfite remains, proteins will be protected against thiol oxidation.



   It was also found that TRIS could be substituted for Bis-Tris in the running buffer with no visible effect on the separation quality. Bis-Tris may be preferred where the protein will be intentionally  modified post-separation. Bis-Tris is a tertiary amine and will not interfere with the protein modifying agents which react through primary amines. TRIS, however is the preferred choice for routine use, because it is available at significantly lower cost than Bis-Tris.

 

   While the invention has been explained in relation to its preferred embodiments, it is to be understood that various modifications thereof will become apparent to those skilled in the art. The foregoing disclosure is not intended or to be construed to limit the present invention, or to otherwise exclude any such other embodiments, adaptions, variations and equivalent arrangements, the present invention being limited only by the claims appended hereto and the equivalents thereof. 

Claims

We Claim:
1. A system for gel electrophoresis comprising: an electrophoresis gel having two ends; said gel being saturated with a gel buffer solution; one end of the gel being in contact with an anode buffer solution; the other end the gel being in contact with a cathode buffer solution; said gel buffer solution comprising a monovalent organic amine or substituted amine with a pK near neutrality, titrated with HC1 to a pH of between about pH 6 and about pH 7; said cathode buffer comprising a solution of a zwitterionic buffer selected from the group of MOPS, MES, ACES, MOPSO, TES, HEPES or TAPSO, titrated to a pH of about 7 with sodium hydroxide or an organic base.
2. The system of claim 1 wherein the monovalent organic amine is Bis-Tris.
3. The system of claim 2 wherein the gel is a polyacrylamide gel.
4. The system of claim 3 wherein the cathode buffer solution comprises sulfite.
5. The system of claim 3 wherein the cathode buffer solution comprises a negatively charged thiol.
6. The system of claim 3 wherein the cathode buffer solution comprises TGA.
7. The system of claim 3 wherein the anode buffer comprises TRIS.
8. A system for gel electrophoresis comprising: a precast polyacrylamide electrophoresis gel having two ends; said gel being saturated with a gel buffer solution; one end of the gel being in contact with an anode buffer solution; the other end the gel being in contact with a cathode buffer solution; said gel buffer solution comprising Bis-Tris titrated with HC1 to a pH of between about pH 6 and about pH 7; said cathode buffer comprising a solution of a zwitterionic buffer selected from the group of MOPS, MES, ACES, MOPSO, TES, HEPES or TAPSO, titrated to a pH of about 7 with sodium hydroxide or an organic base.
9. The system of claim 8 wherein the anode buffer comprises TRIS.
10. The system of claim 8 wherein the cathode buffer comprises sulfite.
11. The system of claim 8 wherein the cathode buffer comprises a negatively charged thiol.
12. The system of claim 8 wherein the cathode buffer comprises TGA.
13. A system for gel electrophoresis comprising: a precast polyacrylamide electrophoresis gel having two ends; wherein said gel is saturated with a gel buffer solution; wherein one end of the gel is in contact with an anode buffer solution; wherein the other end of the gel is in contact with a cathode buffer solution; wherein said gel buffer solution comprises a monovalent organic amine or substituted amine; and wherein said cathode buffer comprises sulfite.
PCT/US1995/003647 1994-03-31 1995-03-29 System for ph-neutral longlife precast electrophoresis gel WO1995027197A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP52575995A JP3679117B2 (en) 1994-03-31 1995-03-29 System for neutral pH long-life precast electrophoresis gels
EP95914833A EP0753142B1 (en) 1994-03-31 1995-03-29 System for gel electrophoresis
DE69511389T DE69511389T2 (en) 1994-03-31 1995-03-29 System for gel electrophoresis
CA002186120A CA2186120C (en) 1994-03-31 1995-03-29 System for ph-neutral longlife precast electrophoresis gel
AU21926/95A AU698145B2 (en) 1994-03-31 1995-03-29 System for PH-neutral longlife precast electrophoresis gel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/221,939 US5578180A (en) 1994-03-31 1994-03-31 System for PH-neutral longlife precast electrophoresis gel
US08/221,939 1994-03-31

Publications (1)

Publication Number Publication Date
WO1995027197A1 true WO1995027197A1 (en) 1995-10-12

Family

ID=22830063

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/003647 WO1995027197A1 (en) 1994-03-31 1995-03-29 System for ph-neutral longlife precast electrophoresis gel

Country Status (8)

Country Link
US (5) US5578180A (en)
EP (1) EP0753142B1 (en)
JP (4) JP3679117B2 (en)
KR (1) KR100368955B1 (en)
AU (1) AU698145B2 (en)
CA (1) CA2186120C (en)
DE (1) DE69511389T2 (en)
WO (1) WO1995027197A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783651B1 (en) 1994-03-31 2004-08-31 Invitrogen Corporation System for pH-neutral stable electrophoresis gel
US7282128B2 (en) 2001-07-19 2007-10-16 Applera Corporation Buffers for electrophoresis and use thereof
US7781173B2 (en) 2003-09-25 2010-08-24 Life Technologies Corporation Homogeneous populations of molecules
US8012715B2 (en) 1997-01-08 2011-09-06 Life Technologies Corporation Methods for production of proteins
US9164099B2 (en) 2002-09-12 2015-10-20 Life Technologies Corporation Site-specific labeling of affinity tags in fusion proteins
US9470655B2 (en) 2013-03-15 2016-10-18 Bio-Rad Laboratories, Inc. Polyacrylamide gels for rapid casting, blotting, and imaging, with storage stability
US9486741B2 (en) 2008-09-02 2016-11-08 Bio-Rad Laboratories, Inc. Hydrolysis-resistant polyacrylamide gels
US9733212B2 (en) 2006-07-21 2017-08-15 Life Technologies Corporation Sharply resolving labeled protein molecular weight standards
US11105769B2 (en) 2009-08-24 2021-08-31 Life Technologies Corporation System for rapid high-resolution gel electrophoresis

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578180A (en) * 1994-03-31 1996-11-26 Novel Experimental Technology System for PH-neutral longlife precast electrophoresis gel
US6143154A (en) * 1994-03-31 2000-11-07 Novex System for PH-neutral stable electrophoresis gel
SE9404141D0 (en) * 1994-11-30 1994-11-30 Pharmacia Biotech Ab New buffer system for electrophoresis
US7824532B2 (en) * 1995-04-26 2010-11-02 Life Technologies Corporation Apparatus and method for electrophoresis
US6464850B1 (en) 1998-07-31 2002-10-15 Biowhittaker Molecular Applications, Inc. Method for producing hydrophilic monomers and uses thereof
US6758953B2 (en) 1999-10-28 2004-07-06 Nathan A. Thomas Multistage electrophoresis apparatus and method of use for the separation and purification of cells, particles and solutes
CN1247990C (en) 1999-12-02 2006-03-29 海茂株式会社 Polyacrylamide precast gels for electrophoresis, process for producing the same and electrophoresis method by using the gels
JP3942001B2 (en) * 1999-12-02 2007-07-11 ハイモ株式会社 Polyacrylamide precast gel for electrophoresis, method for producing the same, and method for separating and analyzing proteins
AU759336B2 (en) * 2000-02-18 2003-04-10 Dycent Biotech (Shanghai) Co., Limited Improved electrophoresis gels
AUPQ571400A0 (en) 2000-02-18 2000-03-16 Life Therapeutics Limited Improved electrophoresis gels
US20040014082A1 (en) * 2000-08-11 2004-01-22 Invitrogen Corporation Highly homogeneous molecular markers for electrophoresis
US6562213B1 (en) 2000-08-30 2003-05-13 Ethrog Biotechnology Ltd. Electrophoresis apparatus for simultaneous loading of multiple samples
WO2002071024A2 (en) * 2001-03-08 2002-09-12 Ethrog Biotechnology Ltd. Apparatus and method for electrophoresis
SE0201655D0 (en) * 2002-05-31 2002-05-31 Amersham Biosciences Ab A method of electrophoresis
US7850835B2 (en) * 2003-05-09 2010-12-14 Life Technologies Corporation Solution phase electrophoresis device, components, and methods
US7622028B2 (en) * 2003-05-09 2009-11-24 Life Technologies Corporation Solution phase electrophoresis device, components, and methods
US20050121325A1 (en) * 2003-09-19 2005-06-09 Timothy Updyke Composite compositions for electrophoresis
WO2005031332A1 (en) * 2003-09-22 2005-04-07 Invitrogen Corporation Apparatus for concurrent electrophoresis in a plurality of gels
WO2005036153A1 (en) * 2003-10-07 2005-04-21 Invitrogen Corporation Improved isoelectric focusing gels and methods of use thereof
US20060118418A1 (en) * 2004-12-02 2006-06-08 Mathoor Sivaram Electrophoresis gels and buffers and methods of performing electrophoresis
US8173002B2 (en) * 2005-02-24 2012-05-08 Life Technologies Corporation Electro-blotting devices, systems, and kits, and methods for their use
EP2180316A4 (en) * 2007-08-17 2010-10-20 Hymo Corp Precast gel for electrophoresis, method for production thereof, and use thereof
JP4838358B2 (en) * 2007-08-17 2011-12-14 ハイモ株式会社 Precast gel for electrophoresis, method for producing the same, and method for using the same
WO2010006318A2 (en) * 2008-07-11 2010-01-14 Life Technologies Corporation Electrophoretically enhanced detection of analytes on a solid support
US8945360B2 (en) * 2009-01-27 2015-02-03 Bio-Rad Laboratories, Inc. High-performing electrophoresis gels with extended shelf lives
WO2011134072A1 (en) 2010-04-27 2011-11-03 Dgel Electrosystem Inc. Electrophoresis buffer for faster migration, improved resolution and extended shelf-life
US9250208B2 (en) 2011-07-14 2016-02-02 Dgel Electrosystem Inc. Electrophoresis buffer for extending the useful electrophoresis life of an electrophoresis gel
US9291596B2 (en) 2013-02-12 2016-03-22 Pierce Biotechnology, Inc. Electroblot transfer buffer
USD738527S1 (en) 2013-05-28 2015-09-08 Life Technologies Corporation Electroblotting apparatus
US10208332B2 (en) 2014-05-21 2019-02-19 Integenx Inc. Fluidic cartridge with valve mechanism
EP3209410A4 (en) 2014-10-22 2018-05-02 IntegenX Inc. Systems and methods for sample preparation, processing and analysis
WO2018156880A1 (en) * 2017-02-24 2018-08-30 Life Technologies Corporation Capillary electrophoresis systems, related devices, and related methods
CN112305048B (en) * 2020-12-22 2021-03-30 苏桥生物(苏州)有限公司 Application of MES and SDS buffer solution in reduction of fragment peaks of capillary electrophoresis
CN113325055A (en) * 2021-04-22 2021-08-31 中国人民解放军空军军医大学 Polyacrylamide gel electrophoresis buffer system and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3948743A (en) * 1975-04-14 1976-04-06 Bio-Rad Laboratories Method for gel electrophoresis
US4209373A (en) * 1979-06-01 1980-06-24 Corning Glass Works Acidic agar gel electrochromatography of hemoglobins
US4481094A (en) * 1982-05-17 1984-11-06 Techamerica Group, Inc. Stabilized polyacrylamide gels and system for SDS electrophoresis
EP0518475A1 (en) * 1991-05-31 1992-12-16 Beckman Instruments, Inc. Analysis of samples utilizing capillary electrophoresis
EP0566784A1 (en) * 1990-11-19 1993-10-27 Hymo Corporation Polyacrylamide gel for electrophoresis
US5275708A (en) * 1992-03-20 1994-01-04 Thomas Jefferson University Cetyltrimethylammonium bromide gel electrophoresis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870812A (en) * 1970-04-02 1975-03-11 Gen Foods Corp Protein gel modification
US4139440A (en) * 1977-06-20 1979-02-13 Government Of The United States Electrofocusing in buffers
US4542200A (en) * 1982-02-19 1985-09-17 Fmc Corporation Polyacrylamide cross-linked with a polysaccharide resin as electrophoretic gel medium
CA1206666A (en) * 1982-02-19 1986-06-24 Samuel Nochumson Copolymer of acrylamide and polysaccharide resin as electrophoretic gel medium
US4504641A (en) * 1982-02-19 1985-03-12 Fmc Corporation Polyacrylamide cross-linked with a polysaccharide resin as electrophoretic gel medium
JPS59212751A (en) * 1983-05-19 1984-12-01 Fuji Photo Film Co Ltd Medium material for electrophoresis
US4950708A (en) * 1988-08-29 1990-08-21 Bio-Rad Laboratories, Inc. Stable polyacrylamide gels containing chaotropic agents
WO1992004625A1 (en) * 1990-08-29 1992-03-19 Budin Michov Protein separation by sds electrophoresis in a homogenous gel using a tris-formiate-taurinate buffer system and suitable homogenous electrophoresis plates therefor
JP3071926B2 (en) * 1992-01-28 2000-07-31 第一化学薬品株式会社 Method for producing polyacrylamide gel plate for electrophoresis
US5213669A (en) * 1992-01-31 1993-05-25 Beckman Instruments, Inc. Capillary column containing a dynamically cross-linked composition and method of use
AU6525094A (en) * 1993-03-26 1994-10-24 United States Biochemical Corporation Improved sequencing gel
US5578180A (en) * 1994-03-31 1996-11-26 Novel Experimental Technology System for PH-neutral longlife precast electrophoresis gel

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3948743A (en) * 1975-04-14 1976-04-06 Bio-Rad Laboratories Method for gel electrophoresis
US4209373A (en) * 1979-06-01 1980-06-24 Corning Glass Works Acidic agar gel electrochromatography of hemoglobins
US4481094A (en) * 1982-05-17 1984-11-06 Techamerica Group, Inc. Stabilized polyacrylamide gels and system for SDS electrophoresis
EP0566784A1 (en) * 1990-11-19 1993-10-27 Hymo Corporation Polyacrylamide gel for electrophoresis
EP0518475A1 (en) * 1991-05-31 1992-12-16 Beckman Instruments, Inc. Analysis of samples utilizing capillary electrophoresis
US5275708A (en) * 1992-03-20 1994-01-04 Thomas Jefferson University Cetyltrimethylammonium bromide gel electrophoresis

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7892409B2 (en) 1994-03-31 2011-02-22 Life Technologies Corporation System for pH-neutral stable electrophoresis gel
US6783651B1 (en) 1994-03-31 2004-08-31 Invitrogen Corporation System for pH-neutral stable electrophoresis gel
US7422670B2 (en) 1994-03-31 2008-09-09 Timothy V Updyke System for pH-neutral stable electrophoresis gel
US7452453B2 (en) 1994-03-31 2008-11-18 Invitrogen Corporation System for pH-neutral stable electrophoresis gel
US7967966B2 (en) 1994-03-31 2011-06-28 Life Technologies Corporation System for pH-neutral stable electrophoresis gel
US8519099B2 (en) 1997-01-08 2013-08-27 Life Technologies Corporation Methods for production of proteins
US9409942B2 (en) 1997-01-08 2016-08-09 Life Technologies Corporation Methods for production of proteins
US8012715B2 (en) 1997-01-08 2011-09-06 Life Technologies Corporation Methods for production of proteins
US8389681B2 (en) 1997-01-08 2013-03-05 Life Technologies Corporation Methods for production of proteins
US8512537B2 (en) 2001-07-19 2013-08-20 Applied Biosystems, Llc Buffers for electrophoresis and use thereof
US7282128B2 (en) 2001-07-19 2007-10-16 Applera Corporation Buffers for electrophoresis and use thereof
US9164099B2 (en) 2002-09-12 2015-10-20 Life Technologies Corporation Site-specific labeling of affinity tags in fusion proteins
US7781173B2 (en) 2003-09-25 2010-08-24 Life Technologies Corporation Homogeneous populations of molecules
US9523692B2 (en) 2003-09-25 2016-12-20 Life Technologies Corporation Homogenous populations of molecules
US9733212B2 (en) 2006-07-21 2017-08-15 Life Technologies Corporation Sharply resolving labeled protein molecular weight standards
US10302591B2 (en) 2006-07-21 2019-05-28 Life Technologies Corporation Sharply resolving labeled protein molecular weight standards
US9486741B2 (en) 2008-09-02 2016-11-08 Bio-Rad Laboratories, Inc. Hydrolysis-resistant polyacrylamide gels
US10119934B2 (en) 2008-09-02 2018-11-06 Bio-Rad Laboratories, Inc. Hydrolysis-resistant polyacrylamide gels
US11105769B2 (en) 2009-08-24 2021-08-31 Life Technologies Corporation System for rapid high-resolution gel electrophoresis
US9470655B2 (en) 2013-03-15 2016-10-18 Bio-Rad Laboratories, Inc. Polyacrylamide gels for rapid casting, blotting, and imaging, with storage stability

Also Published As

Publication number Publication date
CA2186120C (en) 2005-06-21
US6096182A (en) 2000-08-01
EP0753142A1 (en) 1997-01-15
JP2004163442A (en) 2004-06-10
US6059948A (en) 2000-05-09
AU2192695A (en) 1995-10-23
JP4055862B2 (en) 2008-03-05
JP3679117B2 (en) 2005-08-03
JP2007263976A (en) 2007-10-11
CA2186120A1 (en) 1995-10-12
KR100368955B1 (en) 2003-04-11
DE69511389T2 (en) 2000-04-20
US6162338A (en) 2000-12-19
JP3934114B2 (en) 2007-06-20
JP2006177986A (en) 2006-07-06
JPH09512907A (en) 1997-12-22
DE69511389D1 (en) 1999-09-16
US5922185A (en) 1999-07-13
EP0753142B1 (en) 1999-08-11
US5578180A (en) 1996-11-26
AU698145B2 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
AU698145B2 (en) System for PH-neutral longlife precast electrophoresis gel
US7967966B2 (en) System for pH-neutral stable electrophoresis gel
US5470916A (en) Formulations for polyacrylamide matrices in electrokinetic and chromatographic methodologies
Goldenberg et al. Gel electrophoresis in studies of protein conformation and folding
US9486741B2 (en) Hydrolysis-resistant polyacrylamide gels
JP5619165B2 (en) A system for high-speed, high-resolution gel electrophoresis.
US3948743A (en) Method for gel electrophoresis
US6143154A (en) System for PH-neutral stable electrophoresis gel
JP3553604B2 (en) A new buffer system for electrophoresis and its use
US20060118418A1 (en) Electrophoresis gels and buffers and methods of performing electrophoresis
US20100213060A1 (en) Aqueous transfer buffer
Jones et al. A method for the preparation of low-pH dodecyl sulphate/polyacrylamide-gradient gels.
AU2007243994B2 (en) Electrodic bridge
EP3362786A1 (en) Electrophoresis gel with extended shelf life and high performance
Westermeier 5 Slab gel IEF
GELFI PIER GIORGIO RIGHETTI, ALESSANDRA BOSSI, and
Posch et al. Principles and Challenges of Basic Protein Separation by Two-Dimensional (2D) Electrophoresis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NL NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2186120

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1019960705350

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 1995914833

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1995914833

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 1995914833

Country of ref document: EP